HK1204433A1 - 包含 的抑制劑的固體形式、其組合物及其用途 - Google Patents

包含 的抑制劑的固體形式、其組合物及其用途

Info

Publication number
HK1204433A1
HK1204433A1 HK15104987.0A HK15104987A HK1204433A1 HK 1204433 A1 HK1204433 A1 HK 1204433A1 HK 15104987 A HK15104987 A HK 15104987A HK 1204433 A1 HK1204433 A1 HK 1204433A1
Authority
HK
Hong Kong
Prior art keywords
hcv ns5a
inhibitors
compositions
solid forms
uses therewith
Prior art date
Application number
HK15104987.0A
Other languages
English (en)
Inventor
洛里默 基思
穆可尼克
Original Assignee
Presidio Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Presidio Pharmaceuticals Inc filed Critical Presidio Pharmaceuticals Inc
Publication of HK1204433A1 publication Critical patent/HK1204433A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK15104987.0A 2012-02-13 2015-05-26 包含 的抑制劑的固體形式、其組合物及其用途 HK1204433A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261598249P 2012-02-13 2012-02-13
PCT/US2013/025995 WO2013123092A1 (en) 2012-02-13 2013-02-13 Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith

Publications (1)

Publication Number Publication Date
HK1204433A1 true HK1204433A1 (zh) 2015-11-20

Family

ID=48984669

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104987.0A HK1204433A1 (zh) 2012-02-13 2015-05-26 包含 的抑制劑的固體形式、其組合物及其用途

Country Status (21)

Country Link
US (1) US20150203474A1 (zh)
EP (1) EP2814322A4 (zh)
JP (1) JP2015506987A (zh)
KR (1) KR20140145126A (zh)
CN (1) CN104219953A (zh)
AR (1) AR093738A1 (zh)
AU (1) AU2013221613A1 (zh)
BR (1) BR112014019585A8 (zh)
CA (1) CA2864342A1 (zh)
CL (1) CL2014002138A1 (zh)
CO (1) CO7061084A2 (zh)
EA (1) EA201491442A1 (zh)
HK (1) HK1204433A1 (zh)
IN (1) IN2014MN01671A (zh)
MX (1) MX2014009693A (zh)
PE (1) PE20142462A1 (zh)
PH (1) PH12014501781A1 (zh)
SG (1) SG11201404754TA (zh)
TW (1) TW201339153A (zh)
WO (1) WO2013123092A1 (zh)
ZA (1) ZA201406740B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717712B2 (en) 2013-07-02 2017-08-01 Bristol-Myers Squibb Company Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
US20150023913A1 (en) 2013-07-02 2015-01-22 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
JP2016527232A (ja) 2013-07-17 2016-09-08 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｈｃｖの治療に使用するためのビフェニル誘導体を含む組み合わせ
TW202014413A (zh) 2014-06-11 2020-04-16 美商基利法瑪席特有限責任公司 製備抗病毒化合物之方法
ITUB20152784A1 (it) * 2015-08-03 2017-02-03 Chemelectiva S R L Processo per la sintesi di ravidasvir
US10617675B2 (en) 2015-08-06 2020-04-14 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
CN109134439A (zh) * 2017-06-15 2019-01-04 歌礼生物科技（杭州）有限公司 丙肝治疗药物Ravidasvir的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7894996B2 (en) * 2005-02-28 2011-02-22 The Rockefeller University Structure of the hepatitis C NS5A protein
EP2373172B1 (en) * 2008-12-03 2013-07-17 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
KR101411889B1 (ko) * 2009-02-27 2014-06-27 이난타 파마슈티칼스, 인코포레이티드 Ｃ형 간염 바이러스 억제제
WO2011004276A1 (en) * 2009-07-06 2011-01-13 Pfizer Limited Hepatitis c virus inhibitors
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
MX2012010252A (es) * 2010-03-04 2013-02-01 Enanta Pharm Inc Agentes farmaceuticos en combinacion como inhibidores de la replicacion del virus de hepatitis c (hcv).
EP2575866A4 (en) * 2010-05-24 2013-10-16 Presidio Pharmaceuticals Inc HCV NS5A INHIBITORS

Also Published As

Publication number Publication date
EA201491442A1 (ru) 2015-01-30
CO7061084A2 (es) 2014-09-19
WO2013123092A1 (en) 2013-08-22
KR20140145126A (ko) 2014-12-22
CN104219953A (zh) 2014-12-17
EP2814322A1 (en) 2014-12-24
ZA201406740B (en) 2016-02-24
CL2014002138A1 (es) 2014-11-28
AU2013221613A1 (en) 2014-09-04
BR112014019585A8 (pt) 2017-07-11
PE20142462A1 (es) 2015-02-01
MX2014009693A (es) 2014-09-08
US20150203474A1 (en) 2015-07-23
BR112014019585A2 (zh) 2017-06-20
SG11201404754TA (en) 2014-09-26
JP2015506987A (ja) 2015-03-05
TW201339153A (zh) 2013-10-01
CA2864342A1 (en) 2013-08-22
AR093738A1 (es) 2015-06-24
PH12014501781A1 (en) 2014-11-10
EP2814322A4 (en) 2015-09-23
IN2014MN01671A (zh) 2015-05-29

Similar Documents

Publication Publication Date Title
IL252063A0 (en) dna-pk suppressors, preparations containing them and their uses
IL250824B (en) Certain amino-pyrimidines, their assemblies, and methods of using them
IL238958A0 (en) Glutamase inhibitors, preparations containing them and their uses
HK1201186A1 (zh) 包含 抑制劑的固體組合物
IL238959A0 (en) Glutamase inhibitors, preparations containing them and their uses
AP3576A (en) Inhibitors of flaviviridae viruses
EP2575866A4 (en) HCV NS5A INHIBITORS
EP2575475A4 (en) HCV NS5A INHIBITORS
HK1171443A1 (zh) 黃病毒科病毒的抑制劑
IL241330A0 (en) pk - dna suppressor compounds, preparations containing them and their uses
IL233503A0 (en) Isocitrate dehydrogenase inhibitors, preparations containing them and their uses
IL235155B (en) Arginase inhibitor compounds, compositions comprising same and uses thereof
LT2920149T (lt) 3-aminocikloalkilo junginiai, kaip ror-gama-t inhibitoriai, ir jų panaudojimas
PL2850085T3 (pl) Antywirusowe związki inhibitorowe hcv ns5a
EP2785668A4 (en) LIQUIDIZED COMPOSITIONS, MANUFACTURING METHOD AND USES THEREOF
HK1204433A1 (zh) 包含 的抑制劑的固體形式、其組合物及其用途
EP2582664A4 (en) PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
EP2802574A4 (en) INHIBITORS OF HCV NS3 PROTEASE
HK1200847A1 (zh) 的抑制劑
EP2906041A4 (en) COMPOSITIONS AND METHODS OF USING INAPPETENCE COMPOUND
EP2807256A4 (en) MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE
EP2859071A4 (en) CHEMICAL COMPOSITIONS AND METHODS OF USE
GB201120470D0 (en) Compositions and uses thereof